These data strongly suggest that CDA1 is an appropriate and promising molecular target with safety and effectiveness in blocking the pro-fibrotic effect of TGF-β, thus preventing, retarding, or treating PF. This evidence concerns the gene TGFB1 and pemphigus foliaceus.